Arcutis Biotherapeutics's chart data is dated 2026-10-08. There is no active technical signal. There are 2 published signal records.
Arcutis Biotherapeutics last closed at $24.49 (+1.32%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is 116.7×. Its overall grade ranks 214 of 738 stocks in Healthcare.
About this company
Arcutis Biotherapeutics last closed at $24.49 (+1.32%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A- · 214/738
Valuation grade F
Related stocks
- Eli LillyCompetitor
면역·피부질환 치료제 시장의 대형 경쟁사
- IncyteCompetitor
피부질환·면역질환 치료제 분야 경쟁사
- PfizerCompetitor
피부·염증성 질환 포함 대형 제약 경쟁사
About Arcutis Biotherapeutics
- What technical signals does Arcutis Biotherapeutics (ARQT) have?
- Arcutis Biotherapeutics current technical signals: no active technical signal.
- Is Arcutis Biotherapeutics a cup-and-handle pattern?
- No. Arcutis Biotherapeutics has no valid Cup signal right now.
- What published figures are available for Arcutis Biotherapeutics?
- Market cap: $3B. Trailing 12 months PER: 116.7×. Latest quarter PBR: 15.09×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Arcutis Biotherapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.